Gilon D, Slater P E, Benbassat J
J Clin Gastroenterol. 1991 Jun;13(3):255-8.
We explore the trade-off between the risk and expected benefits from resection of giant liver hemangioma (GLH), one larger than 4 cm in diameter. We searched the English-language literature for studies of the postoperative mortality after resection of GLH and of the outcome of expectantly treated patients. The results of the data synthesis showed an operative mortality of 1.5% (90% confidence intervals, 0.1-3.0%) and an early surgical morbidity of up to 13%. Mortality among the 37 reported cases with ruptured GLH was 78%. There were no cases of spontaneous or traumatic rupture of unresected GLH during a follow-up of a total of 282 patient years. The main source of ambiguity regarding the management of GLH is the uncertain risk of its rupture. Rough estimates of this risk based on published data suggest that surgical resection is not justified in asymptomatic GLH. Yet, although rare, rupture of GLH does occur with disastrous consequences. Future research may attempt to define patient subsets whose GLHs are at higher risk of rupture, and in whom preventive resection may improve survival.
我们探讨了直径大于4厘米的巨大肝血管瘤(GLH)切除手术的风险与预期获益之间的权衡。我们检索了英文文献,以研究GLH切除术后的死亡率以及接受观察等待治疗患者的预后情况。数据综合分析结果显示,手术死亡率为1.5%(90%置信区间为0.1 - 3.0%),早期手术并发症发生率高达13%。37例报告的GLH破裂病例的死亡率为78%。在总计282患者年的随访期间,未切除的GLH没有发生自发性或外伤性破裂的病例。GLH治疗方面主要的不确定性来源是其破裂风险不确定。根据已发表数据对该风险的粗略估计表明,对于无症状的GLH,手术切除并不合理。然而,尽管GLH破裂很少见,但一旦发生则会带来灾难性后果。未来的研究可能会尝试确定哪些患者亚组的GLH破裂风险较高,以及预防性切除可能改善其生存情况。